Suchergebnisse - "Babizhayev, Mark A"

PubPharm (94)

1

Generation of reactive oxygen species in the anterior eye segment. Synergistic codrugs of N-acetylcarnosine lubricant eye drops and mitochondria-targeted antioxidant act as a powerful therapeutic platform for the treatment of cataracts and primary open-angle glaucoma

enthalten in: BBA clinical | 2016

von Babizhayev, M.

2

Telomere Attrition in Human Lens Epithelial Cells Associated with Oxidative Stress Provide a New Therapeutic Target for the Treatment, Dissolving and Prevention of Cataract with N-Acetylcarnosine Lubricant Eye Drops. Kinetic, Pharmacological and Activity-Dependent Separation of Therapeutic Targeting : Transcorneal Penetration and Delivery of L-Carnosine in the Aqueous Humor and Hormone-Like Hypothalamic Antiaging Effects of the Instilled Ophthalmic Drug Through a Safe Eye Medication Technique

enthalten in: Recent patents on drug delivery & formulation | 2016

von Babizhayev, M. | Yegorov, Y.

3

Reactive Oxygen Species and the Aging Eye : Specific Role of Metabolically Active Mitochondria in Maintaining Lens Function and in the Initiation of the Oxidation-Induced Maturity Onset Cataract--A Novel Platform of Mitochondria-Targeted Antioxidants With Broad Therapeutic Potential for Redox Regulation and Detoxification of Oxidants in Eye Diseases

enthalten in: American journal of therapeutics | 2016

von Babizhayev, M. | Yegorov, Y.

4

Tissue formation and tissue engineering through host cell recruitment or a potential injectable cell-based biocomposite with replicative potential : Molecular mechanisms controlling cellular senescence and the involvement of controlled transient telomerase activation therapies

enthalten in: Journal of biomedical materials research. Part A | 2015

von Babizhayev, M. | Yegorov, Y.

5

The Role of Oxidative Stress in Diabetic Neuropathy : Generation of Free Radical Species in the Glycation Reaction and Gene Polymorphisms Encoding Antioxidant Enzymes to Genetic Susceptibility to Diabetic Neuropathy in Population of Type I Diabetic Patients

enthalten in: Cell biochemistry and biophysics | 2015

von Babizhayev, M. | Strokov, I. | Nosikov, V. | +4

6

The Role of Oxidative Stress in Diabetic Neuropathy: Generation of Free Radical Species in the Glycation Reaction and Gene Polymorphisms Encoding Antioxidant Enzymes to Genetic Susceptibility to Diabetic Neuropathy in Population of Type I Diabetic Patients

enthalten in: Cell biochemistry and biophysics | 2015

von Babizhayev, M. | Strokov, I. | Nosikov, V. | +3

7

Hormone-brain-aging relationships, broadly reactive with imidazole-containing dipeptides : targeting of telomere attrition as an aging biomarker and dynamic telomerase activity flirting

enthalten in: Journal of basic and clinical physiology and pharmacology | 2015

von Babizhayev, M. | Vishnyakova, K. | Yegorov, Y.

8

Functional Performance of L-Carnosine ( -Alanyl-L-Histidine) and Related Imidazole-Containing Dipeptides. Design and Modern Applications of Drug Delivery Systems (Nanosuspensions of Nanosize Materials, Mucoadhesive Drug Delivery Systems, Formulations of Transdermal Patches for Controlled Drug Delivery) Leads to Functional Recovery in Ischemic Stroke

enthalten in: Recent patents on drug delivery & formulation | 2015

von Babizhayev, M.

9

An "enigmatic" L-carnosine (β-alanyl-L-histidine)? Cell proliferative activity as a fundamental property of a natural dipeptide inherent to traditional antioxidant, anti-aging biological activities : balancing and a hormonally correct agent, novel patented oral therapy dosage formulation for mobility, skeletal muscle power and functional performance, hypothalamic-pituitary- brain relationship in health, aging and stress studies

enthalten in: Recent patents on drug delivery & formulation | 2015

von Babizhayev, M. | Yegorov, Y.

10

Patenting strategies, the authentication US fiscal methodology, discovery and development of imidazole-containing peptide compounds with free-radical scavenging and transglycating properties acting as targeted drug regulators and homeostatic agents with diverse therapeutic activities for pharmacy of diabetes and metabolic diseases

enthalten in: Expert opinion on therapeutic patents | 2015

von Babizhayev, M.

RetractionIn: Expert Opin Ther Pat. 2017 Dec;27(12 ):1363. - PMID 29119843

1
2
3
4
5
6
7
8
9
10
Nächster »
[10]